Valneva reports FY results; gives FY26 outlook
Source: SeekingAlpha
2026-03-18 02:24:19 ET
More on Valneva
- Valneva sees lower 2026 sales as third-party revenue winds down
- Valneva chikungunya shot no longer recommended for older adults in U.K.
- Seeking Alpha’s Quant Rating on Valneva
- Historical earnings data for Valneva
- Financial information for Valneva
Read the full article on Seeking Alpha
For further details see:
Valneva reports FY results; gives FY26 outlook
Valneva SE
NASDAQ: INRLF
INRLF Trading
0.0% G/L:
$3.50 Last:
170 Volume:
$3.50 Open:
INRLF Latest News
March 09, 2026 12:45:00 pm
Valneva to Report Full Year 2025 Consolidated Financial Results on March 18, 2026
February 19, 2026 01:00:00 am
Valneva Reports Preliminary Unaudited 2025 Revenue and Cash and Provides 2026 Outlook
INRLF Stock Data
$786,522,915
123,310,055
N/A
122
N/A
Biotechnology & Life Sciences
Healthcare
FR
Lyon
